Table:
begin	end	state
1	19	non-cytoplasmic
20	35	transmembrane
36	55	cytoplasmic
56	75	transmembrane
76	86	non-cytoplasmic
87	115	transmembrane
116	146	cytoplasmic
147	168	transmembrane
169	173	non-cytoplasmic
174	195	transmembrane
196	247	cytoplasmic
248	269	transmembrane
270	285	non-cytoplasmic
286	309	transmembrane
310	320	cytoplasmic
321	339	transmembrane
340	344	non-cytoplasmic
345	367	transmembrane
368	376	cytoplasmic
377	400	transmembrane
401	406	non-cytoplasmic
407	428	transmembrane
429	436	cytoplasmic

Input:
>Pf6N2E2_5978
MQAHTLSAQASLVTPSRKRFFIMVLLFITVVINYLDRSNLSIAAPALTSDLGIDPIHVGL
IFSAFGWTYAAMQIPGGWLVDRVPPRILYSVALLLWSVATVMLGFAASFIALFVLRMAVG
ALEAPAYPINSRVVTTWFPERERATAIGFYTSGQFVGLAFLTPVLAWLQHAFGWHMVFVA
TGAVGILWAAIWYAVYREPRDFKGANAAEIELIREGGGLVDIQADTAKVKAKFSWSDLGI
VLTQRKLWGIYLGQFCLNSTLWFFLTWFPTYLVKYRGMDFIKSGLLASLPFLAAFVGVLC
SGFFSDWLIRRGATVGFARKLPIIGGLLISTSIIGANFVESTPLVIAFLALAFFGNGLAS
ITWSLVSTLAPARLLGLTGGVFNFIGNLAAIATPIVIGFLASGDSFAPAITYISVLALAG
ALSYILLVGKVERIEL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server